Sepsis is a critical medical condition that escalates rapidly, and national guidelines recommend treatment to begin within 20 minutes of arrival to the emergency department (ED). Michelle M. Ramirez, MD, is leading the Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) study to determine the optimal intravenous fluid type to treat pediatric sepsis. Patients between 6 months and 17 years of age, for whom the ED doctor suspects septic shock, will be enrolled in the study and treated with one of two commonly used intravenous fluid types, along with the best locally available medical care, unless patients opt out or decide to withdraw from study completion.

Learn more about the PRoMPT BOLUS study, how patients will be enrolled, and how families can opt out.